
Cardiac Dysfunction in Chronic Uremia
Kluwer Academic Publishers
Published on 30. November 1991
Book
Hardback
XIV, 318 pages
978-0-7923-1351-9 (ISBN)
Description
Cardiac disease is the major cause of death in dialysis patients, accounting for over one third of deaths. This book focuses on myocardial function and dysfunction in chronic uremia. It is aimed at practicing and training nephrologists, cardiologists, and internists, and at research workers in the field. We have tried to produce an up-to-date, in-depth review of the subject by inviting experts in clinical epidemiology, pathophysiology, and thera peutics to write the 18 chapters. The book is divided into three sections. The first section comprises five chapters that provide an overview of the burden of illness associated with cardiac disease in end-stage renal disease and a review of clinical epidemi ological aspects of various cardiac diseases that occur in renal patients. The second section discusses abnormalities of left ventricular contractility and mass, and the factors that predispose to both systolic and diastolic disorders. The importance of hypertension, anemia, hyperparathyroidism, hyper lipidemia, and diabetes mellitus in predisposing to these abnormalities is reviewed splendidly by researchers active in these areas. The final section concentrates on therapeutics. Data and opinion on management of congestive heart failure, cardiomyopathy, coronary artery disease, hypertension, and arrhythmias are provided. In editing this book, we have reviewed an extensive literature, but un fortunately we have become more aware that substantial gaps in our knowl edge exist. Insufficient high-quality clinical research has been undertaken xiii xiv Preface regarding the various cardiac diseases that occur in end-stage renal disease.
Reviews / Votes
' .....and altogether it is a first-class review of the subject. ' Nephrology Dialysis Transplant 8:2: 1993' I recommend this book to anyone who is involved in the management of ESRD patients or in the investigation of heart disease in the ESRD population. ' Dialysis & Transplantation 22:2: 1993
' This book brings together a great deal of valuable information that should be of interest all nephrologists ' The Lancet 340 1992
More details
Series
Edition
1992 ed.
Language
English
Place of publication
New York
United States
Target group
Professional and scholarly
Research
Product notice
sewn/stitched
Cloth over boards
Illustrations
XIV, 318 p.
Dimensions
Height: 234 mm
Width: 156 mm
Thickness: 19 mm
Weight
644 gr
ISBN-13
978-0-7923-1351-9 (9780792313519)
DOI
10.1007/978-1-4615-3902-5
Schweitzer Classification
Other editions
Additional editions

Patrick Parfrey | John D. Harnett
Cardiac Dysfunction in Chronic Uremia
E-Book
12/2012
Springer
€213.99
Available for download

Patrick Parfrey | John D. Harnett
Cardiac Dysfunction in Chronic Uremia
Book
10/2012
Springer
€213.99
Shipment within 7-9 days
Content
I. Epidemiology.- 1. Cardiac disease in chronic uremia: An overview.- 2. Lessons from Framingham: Cardiac disease in the general population.- 3. The natural history of myocardial disease in dialysis patients.- 4. Ischemic heart disease in chronic renal failure: Demography, epidemiology, and pathogenesis.- 5. Cardiac arrhythmias in end-stage renal disease: Prevalence, risk factors, and management.- II. Pathogenesis.- 6. Cardiac pathology in chronic renal failure.- 7. Etiology of left ventricular dysfunction in end-stage renal failure.- 8. Left ventricular dysfunction in end-stage renal disease: Echocardiographic insights.- 9. Parathyroid hormone and the myocardiopathy of chronic renal failure.- 10. Anemia and left ventricular function in end-stage renal disease.- 11. The effect of dialysis on left ventricular contractility.- 12. Atherogenesis in chronic renal failure.- 13. The heart in diabetic nephropathy.- III. Management.- 14. The management of congestive heart failure in uremic patients.- 15. The management of coronary artery disease in patients with end-stage renal disease.- 16. Therapy of hypertension in end-stage renal disease.- 17. The use of cardiovascular drugs in chronic renal failure.- 18. Dialysis therapy in patients with cardiac disease.